| Pro-active Genetic Testing in Kidney Transplant Patients (NCT05298904) | Mayo Clinic | 2022-03-28 |
| Impact of Double J Catheter in Major Urological Complications in Renal Transplant Recipients (NCT07008131) | Instituto Mexicano del Seguro Social | 2022-01-01 |
| Use of Predigraft in Kidney Transplant Patients (NCT04969757) | Assistance Publique - Hôpitaux de Paris | 2021-11-23 |
| Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients (NCT05029310) | Oslo University Hospital | 2021-09-01 |
| Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients (NCT04963673) | Centre Hospitalier Universitaire, Amiens | 2021-07-06 |
| Validation Study of the Feasibility of an Integrated Diagnostic System of Anatomo-pathological Lesions - Including Rejections - Appearing in Renal Grafts in the First Year of Transplant for Applicability in Routine Clinical Practice : KTD Innov-2 Study (NCT04581278) | Nantes University Hospital | 2021-06-02 |
| Antibody After COVID-19 Vaccination (NCT05057936) | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 2021-06-01 |
| Transversus Abdominis Plane Catheter Following Kidney Transplantation (NCT04786470) | Western University, Canada | 2021-05-01 |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults (NCT04952766) | Centre Hospitalier Régional d'Orléans | 2021-03-26 |
| The Use of a Consumer-Based mHealth Dietary App and Health Coaching With Kidney Transplant Recipients (NCT05151445) | Ohio State University | 2021-03-01 |
| The KidneyCARE (Community Access to Research Equity) Study (NCT05497518) | Tufts Medical Center | 2021-02-25 |
| Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2 (NCT05125913) | Grigore T. Popa University of Medicine and Pharmacy | 2021-01-04 |
| Pilot Social Support Counseling Intervention for Kidney Transplant Candidates (NCT04363515) | Hennepin Healthcare Research Institute | 2020-08-01 |
| SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) (NCT04487197) | Antonio Secchi | 2020-07-15 |
| Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients (NCT04377776) | IRCCS San Raffaele | 2020-05-04 |
| A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients (NCT03504137) | Johns Hopkins University | 2020-03-04 |
| Microbiome and Immunosuppression: The Mission Study (NCT04953715) | The University of Texas Medical Branch, Galveston | 2020-02-12 |
| First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients (NCT04431219) | Xenothera SAS | 2019-11-26 |
| Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor (NCT03707262) | Jeffrey Veale, MD | 2019-11-06 |
| Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies (NCT03837522) | St. Louis University | 2019-09-17 |
| Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant (NCT04087720) | Amgen | 2019-09-09 |
| Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (NCT03978494) | Sandoz | 2019-09-02 |
| Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation (NCT03607500) | University of Michigan | 2019-08-22 |
| Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients (NCT04023760) | University of Saskatchewan | 2019-06-26 |
| NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation (NCT03866421) | Rigshospitalet, Denmark | 2019-05-29 |
| Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study (NCT03726307) | Angus W. Thomson PhD DSc | 2019-04-10 |
| Utilization of Hepatitis C Positive Kidneys in Negative Recipients (NCT03801707) | Ohio State University | 2019-03-22 |
| A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients (NCT03284242) | Roberto Gedaly | 2019-03-15 |
| Reducing Disparities in Living Donor Transplant Among African Americans (NCT03819686) | Emory University | 2019-02-04 |
| Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in Low-risk CMV-seropositive Kidney Transplant Recipients (NCT07621835) | Maimónides Biomedical Research Institute of Córdoba | 2019-01-01 |
| Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) (NCT04224350) | Chong Kun Dang Pharmaceutical | 2018-12-17 |
| Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients (NCT03713645) | Temple University | 2018-11-12 |
| Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients (NCT03644485) | Astellas Pharma China, Inc. | 2018-10-21 |
| Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine (NCT03527238) | University of Florida | 2018-09-21 |
| Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients (NCT03749356) | Chong Kun Dang Pharmaceutical | 2018-09-05 |
| The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients (NCT03558373) | Chiesi Farmaceutici S.p.A. | 2018-07-31 |
| Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates (NCT03535584) | Mayo Clinic | 2018-06-12 |
| A Randomized Controlled Trial of a Pre-Transplant Education Intervention (NCT03633136) | University of Saskatchewan | 2018-06-01 |
| Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial (NCT03104868) | Northwestern University | 2018-05-03 |
| Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome (NCT03794492) | Chong Kun Dang Pharmaceutical | 2018-03-31 |
| Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation (NCT03423901) | University Hospital, Toulouse | 2018-02-06 |
| PGDT in Patients Undergoing Kidney Transplant (NCT05035537) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2018-01-01 |
| Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. (NCT04102943) | Chong Kun Dang Pharmaceutical | 2017-11-30 |
| Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients (NCT03249194) | Virginia Commonwealth University | 2017-08-17 |
| Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial (NCT03045276) | Children's Hospital of Philadelphia | 2017-06-29 |
| Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients (NCT02990312) | University of Maryland, Baltimore | 2017-05-01 |
| Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association (NCT03228576) | Poitiers University Hospital | 2017-04-14 |
| Sargramostim for Myeloid Dendritic Cell Deficiency (NCT03063242) | University of Florida | 2017-02-23 |
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation (NCT02711826) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-20 |
| A Cohort Study of Operationally Tolerant Allograft Recipients (NCT02743793) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-30 |
| Collaborative Care Intervention for Chronic Kidney Disease (NCT02938351) | University of Pittsburgh | 2016-06-01 |
| Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant (NCT02429869) | University of California, San Francisco | 2016-02-24 |
| Preparing for Kidney Transplant by Attaining a Healthy Weight (NCT02986243) | University of Chicago | 2016-02-01 |
| Effects of Inhibiting Early Inflammation in Kidney Transplant Patients (NCT02495077) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-02 |
| The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema (NCT01860820) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-06-01 |
| Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients (NCT02409901) | University of Illinois at Chicago | 2014-10-01 |
| Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (NCT02182986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-14 |
| Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients (NCT02377791) | Mahidol University | 2014-07-01 |
| A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant (NCT02057484) | Astellas Pharma Europe Ltd. | 2014-03-03 |
| Transplant Navigator Dissemination (NCT01981603) | Catherine Sullivan | 2014-01-01 |
| A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients (NCT02034747) | Astellas Pharma Korea, Inc. | 2013-11-21 |
| Transversus Abdominis Plane Block During Kidney Transplant Surgery (NCT02080728) | Centre Hospitalier Universitaire Dijon | 2013-07-23 |
| Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function (NCT01837043) | Nair, Vinay, D.O. | 2013-06-01 |
| Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients (NCT01791491) | Bristol-Myers Squibb | 2013-05-09 |
| Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation (NCT02528591) | Centre Hospitalier Universitaire de Saint Etienne | 2013-03-01 |
| A Prospective, Open Label Study of CERtican in KIdney Transplantation (NCT01594268) | Novartis Pharmaceuticals | 2012-03-01 |
| Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population (NCT01914354) | The Cleveland Clinic | 2012-02-01 |
| Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults (NCT01455649) | Deise de Boni Monteiro de Carvalho | 2011-11-01 |
| Prospective Donor Specific Antibody (DSA) Monitoring Protocol (NCT01382355) | Providence Health & Services | 2011-08-01 |
| Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients (NCT01289717) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates (NCT01261910) | St. Barnabas Medical Center | 2010-12-01 |
| ACtive Care After Transplantation, the ACT Study (NCT01047410) | University Medical Center Groningen | 2010-10-01 |
| ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients (NCT07436338) | Seoul National University Hospital | 2010-10-01 |
| Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression- (NCT01166724) | The Cleveland Clinic | 2010-07-01 |
| Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation (NCT01095887) | Mayo Clinic | 2010-05-01 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant (NCT01106027) | Mayo Clinic | 2010-03-01 |
| Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients (NCT01025817) | Novartis Pharmaceuticals | 2010-01-01 |
| Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients (NCT01021943) | Instituto Nacional de Cardiologia Ignacio Chavez | 2009-11-01 |
| Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation (NCT00940940) | University of Alberta | 2009-10-01 |
| Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients (NCT00895583) | Pfizer | 2009-06-01 |
| Tacrolimus to Sirolimus Conversion for Delayed Graft Function (NCT00931255) | University of Maryland, Baltimore | 2009-04-01 |
| Intensive Insulin Therapy in Deceased Donors (NCT01140035) | University of California, San Francisco | 2009-01-01 |
| Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients (NCT00663455) | University of Erlangen-Nürnberg Medical School | 2008-12-01 |
| Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (NCT00752479) | Mario Negri Institute for Pharmacological Research | 2008-05-01 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant (NCT00670774) | Mark Stegall | 2008-03-01 |
| Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients (NCT01802268) | Helio Tedesco Silva Junior | 2008-02-01 |
| Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus (NCT00502242) | Pfizer | 2007-12-01 |
| Cell-mediated Immune Response to Influenza Vaccine (NCT00677547) | University of Alberta | 2007-11-01 |
| Melatonin and Adiponectin in Hypertensive Kidney Transplant (NCT00498576) | Sheba Medical Center | 2007-09-01 |
| Observational Registry Study of Renal Transplant Patients (NCT01284257) | Novartis Pharmaceuticals | 2007-06-01 |
| MMF vs. AZA for Kidney Transplantation (NCT00494741) | Mario Negri Institute for Pharmacological Research | 2007-05-01 |
| Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant (NCT00466518) | University of Oklahoma | 2007-04-01 |
| EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function (NCT00302497) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2007-04-01 |
| Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients (NCT00433953) | Children's Hospital Medical Center, Cincinnati | 2007-02-01 |
| Protective Immunity Project 02 (NCT00833651) | Emory University | 2006-11-01 |
| Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS) (NCT00676221) | Foothills Medical Centre | 2006-07-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients (NCT00537862) | Novartis Pharmaceuticals | 2006-05-01 |
| Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies (NCT00307125) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients (NCT00275314) | University of Pittsburgh | 2006-02-01 |
| Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab (NCT01213329) | Northwestern University | 2006-02-01 |